Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.48) per share. This is a 29.73 percent decrease over losses of $(0.37) per share from the same period last year.
Sanctions Workaround? Citroen Cars Roll On In Russia Despite Stellantis Exit, Thanks To Chinese Help
It remains uncertain whether the imported kits from China contained parts that are under Western sanctions on Russia.
